MedTrace Logo

POCT PCT in Outpatient LRTI

NCT05380869 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2022-05-19

No results posted yet for this study

Summary

Lower respiratory tract infections (LRTI) in patients with chronic lung diseases are a common acute reason to consult respiratory practitioners and often lead to inadequate prescription of antibiotics. The primary objective of the investigators study was to determine the diagnostic accuracy of point-of-care testing (POCT) for procalcitonin (PCT) in identifying pneumonia as a bacterial infection in outpatients with LRTI.

Conditions

  • Antimicrobial Stewardship
  • Exacerbation of Allergic Asthma
  • Exacerbation Copd
  • Community-acquired Pneumonia
  • Lower Respiratory Tract and Lung Infections

Interventions

DIAGNOSTIC_TEST

Point-of-care Test

to test Point-of-care procalcitonin in suspected pneumonia

Sponsors & Collaborators

  • Hannover Medical School

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2021-03-31
Completion
2021-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05380869 on ClinicalTrials.gov